Rise in the prevalence of lung cancer and lung-related disorders, surge in the geriatric population, increase in the adoption of technologically advanced medical devices worldwide, spike in the demand for minimally invasive tests for lung diseases, growing R&D activity for pulmonary function testing devices, and mounting healthcare expenditures drive the growth of the global pulmonary …